A
s part of the delivery process, the neonate leaves the mostly germ-free intrauterine environment and enters a highly contaminated extrauterine world. It is thought that the process of intestinal bacterial colonization occurs within the first few hours to days after birth, which initiates the rapid immunological development of the intestine. However, the precise mechanisms of this development are not well understood.
Probiotics are defined as "live microorganisms, which when administered in adequate amounts confer a health benefit to the host" (1) . Lactic acid bacteria, such as lactobacilli and bifidobacteria, are among the best-known candidates for probiotics. In numerous human trials, although the precise mechanisms have not been determined, intake of lactobacilli and bifidobacteria has been reported to be beneficial with respect to stool frequency and stool consistency (2, 3) . The potential benefit of probiotics in the modulation and regulation of the immune response has also been reported in both humans and animals (4) (5) (6) (7) (8) .
Bifidobacterium breve M-16V (B. breve) is a probiotic strain that was isolated from the fecal sample of a healthy baby. Oral administration of B. breve to mice with IgE-mediated hypersensitivity to cow milk or ovalbumin promotes a significant improvement in allergic symptoms (9, 10) . Although B. breve influences bacterial colonization in the intestine and enhances TGF-β1 signaling by regulating Smad7 expression in preterm infants (11, 12) , the precise mechanisms of these interactions have not been well established.
In this study, we investigated the immune-modulatory effects of B. breve during infancy. Gene expression in the rat colon, small intestine, and spleen was examined by microarray and real-time PCR after feeding 5 × 10 8 colony-forming units/animal B. breve to rat pups during the newborn (days [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] or weaning (days 21-34) period.
Results

Intestinal Flora
Intestinal microflora analysis by real-time PCR revealed a significant increase in Bifidobacterium and a decrease in Bacteroides populations, which were confirmed in the cecum and colon, after B. breve administration to newborn rats as compared to controls (P < 0.01 each) (Figure 1a,b) . In contrast, there was not a significant difference in the bacterial density of the cecum or colon in weaning rats administered B. breve (Figure 1c,d ).
Microarray Analysis of Total Gene Expression
Gene expression was examined by microarray using RNA isolated from whole-thickness colon, small intestine, or spleen samples and compared in rats with and without B. breve administration during the newborn and weaning periods. The number of upregulated or downregulated genes with a fold change >1.3 and a P value < 0.05 after B. breve administration was relatively small. 
Effects of B. breve on the rat intestine
The numbers of upregulated and downregulated genes were greater during the weaning period than in the newborn period. Furthermore, the number of genes with significantly changed expression was greatest in the colon, next greatest in the small intestine, and least in the spleen (Figure 2 ).
Functional Categories of Upregulated and Downregulated Genes
The genes with significantly altered expression were divided into seven immunological, functional categories based on the biological processes determined by Ingenuity Pathways Analysis. Histograms of the numbers of upregulated and downregulated genes in each functional category in colon, small intestine, and spleen during the newborn and weaning periods are shown in Figure 3 . The number of changed genes after B. breve administration was greater during the weaning period than in the newborn period. Furthermore, the greatest number of changed genes was observed in the colon, with fewer changed genes in the small intestine, and the fewest changed genes in the spleen. There were almost no changes in gene expression in the spleen after B. breve administration in either the newborn or weaning period.
Microarray Analysis of Typical Gene Expression
The comparison of microarray results in newborn rats with and without B. breve administration showed that 679, 168, and 23 genes in the colon had fold changes >1.2, 1.3, and 1.5, respectively. In addition, 1,071, 214, and 103 genes were significantly different between B. breve-fed rats and controls, with P values < 0.05, 0.01, and 0.005, respectively.
As a result, we identified four genes, Lpl, Gpx2, ClCa4, and Lbp, that had fold changes >1.5 and P values < 0.05 after B. breve administration in the newborn colon ( Table 1) . With regard to these genes, a significant difference was observed only in the colon and not in the small intestine or spleen (Figure 4a) . During the weaning period, no significant changes were observed in the expression of these four genes in the colon, small intestine, or spleen (Figure 4b) .
During the weaning period in rats administered B. breve, genes in the colon with fold changes >1.5 and P values < 0.01 were identified ( Table 2 ). The expression of most of these genes, as listed in Table 2 , was enhanced after B. breve administration rather than decreased as observed in newborn rats. Although the expression of CD3d was significantly increased in the colon, there were no accompanying significant changes in the expression of co-stimulatory molecules (Figure 5b) . These gene changes were observed only in the colon and not in the small intestine or spleen. These changes were not observed in the colon, small intestine, or spleen during the newborn period (Figure 5a ).
Real-Time PCR
Real-time PCR was performed to confirm the changes observed by microarray analysis with samples collected from 14 newborn and 9 weaning rat pups. In the newborn rat pups, the expression Articles Ohtsuka et al.
of Lpl, Gpx2, ClCa4, and Lbp was examined in the colon and compared to the expression of β-actin. The expression of Lpl, Gpx2, and ClCa4, but not Lbp, was significantly downregulated (P < 0.05; Figure 6 ). In the weaning rat pup colon, because the expression of CD3d was significantly enhanced according to microarray analysis, the expression of CD3d and its co-stimulatory molecules CD80, CD86, CD28, and CTLA-4 was examined by real-time PCR to confirm the effect of B. breve on signaling through these molecules. The expression of CD3d was significantly enhanced as compared to controls (P < 0.05), whereas there was no significant difference observed in the expression of co-stimulatory molecules in the colon (Figure 7 ).
Immunohistochemical Analysis
To confirm the effect of B. breve on signaling through CD3 and other co-stimulatory molecules, lymphoid follicles in the colon were stained with anti-CD3 and anti-CD86 antibodies (Figure 8 ). CD3-positive cells were confirmed in both control and B. breve-administered weaning rat pups, and accumulation of staining with anti-CD3 antibody was confirmed in the B. breve group (Figure 8c,d ) as compared with their controls (Figure 8a,b) . The staining with anti-CD86 antibody was also confirmed, but it was light in both groups, and we found no significant difference in staining between the control (Figure 8e,f) and B. breve groups (Figure 8g,h ).
DIsCussION
In this study, we examined the immune-modulatory effects of probiotics during early infancy. B. breve was administered to rat pups during the newborn or weaning period, and the expression of inflammatory genes was investigated in the colon, small intestine, and spleen. Administration of B. breve during the newborn period was associated with a significant increase in the proportion of bifidobacteria and a decrease in the proportion of aerobic bacteria in both the cecum and the colon (P < 0.01 each). Furthermore, these changes were associated with altered expression of Lpl, Gpx2, and ClCa4 during the newborn period (fold change > 1.5, P < 0.05). Enhanced expression of Lpl has been observed in dextran sulfate sodium-induced colitis in hamsters (18) . ClCa4 is considered to be an important molecule for the induction of diarrhea in cystic fibrosis (19) . Gpx2 is a marker for the colonic inflammation that occurs in experimental colitis and inflammatory bowel diseases (20) (21) (22) . It has been suggested that all of these molecules are involved in the pathogenesis of inflammatory changes in the intestine. Therefore, downregulating the expression of these molecules by the administration of B. breve may be beneficial for avoiding inflammation, e.g., necrotizing enterocolitis, in newborns.
The immune system of the gut is continually exposed to benign foreign proteins, including foods, and yet, at the same time, the immune system must be able to react to pathogenic foreign proteins. To address this dichotomy, the gut immune system has acquired mechanisms to avoid excessive reactions to foods, known as tolerance. Previous reports on the induction of tolerance through administration of probiotics have mainly been focused on lactobacilli (23) . Therefore, we used B. breve to examine its effect on tolerance. Although a number Gene expression data had a fold change >1.5 with P < 0.01.
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of genes were significantly upregulated in the colon, including CD3d, the group of changed genes did not include those for co-stimulatory molecules. To further validate the effect of B. breve on CD3 and co-stimulatory molecules, lymphoid follicles in the colon were stained with anti-CD3 and anti-CD86 antibodies. Accumulation of staining with anti-CD3 antibody but not with CD86 antibody was confirmed in B. breveadministered weaning rat pups (Figure 8 ).
Because administration of B. breve enhanced the expression of CD3 but not co-stimulatory molecules, this bacterium would be beneficial for introducing tolerance to benign foreign peptides during the weaning period.
The administration of B. breve influenced gene expression during the newborn period and the weaning period in distinct ways. The total number of genes upregulated or downregulated (fold change > 1.5, P < 0.05) was ~10 times larger in 
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Effects of B. breve on the rat intestine the weaning group than in the newborn group; moreover, the changed genes were mostly observed in the colon, with few present in the small intestine and even fewer present in the spleen. One possible explanation for these observations is related to the differences in the total amounts of antigens encountered in various regions of the intestine. Because a larger number of food proteins enter the intestinal lumen during the weaning period than in the newborn period, and because B. breve tends to stay longer in the colon than in the small intestine, B. breve may primarily influence local immune reactions in the colon but not systemic reactions. Furthermore, B. breve may not be a strong, systemic immune regulator but rather may be capable of mildly modulating immune reactions by introducing tolerance. However, there is an additional possibility that larger amounts of B. breve could be administered to introduce significant changes in systemic immune reactions. There were no significant differences in the mRNA levels of cytokines after B. breve administration in this study. O'Mahony et al. (24) reported a model of cytokine production under stimulation with anti-CD3 and anti-CD28 antibodies using splenocytes. Because our study simply examined the mRNA levels of cytokines and other signaling molecules without any stimulation, we cannot directly compare our results to theirs. However, O'Mahony et al. also reported that TNF-α and IFN-γ production from splenocytes of mice fed B. breve was reduced after stimulation with anti-CD3 and anti-CD28 compared with controls. These results suggest that B. breve regulates cytokine synthesis directly and indirectly.
Probiotics are useful for regulating inflammation as well as allergic reactions (25) . Although lactobacilli and bifidobacteria are often used as probiotics, their functions seem to be different. Nonaka et al. suggested that lactobacilli modulate the Th1/Th2 immune balance toward Th1 reactions (8) . Shima et al. reported that the Lactobacillus casei strain Shirota enhances the expression of genes involved in defense/ immune functions and in lipid metabolism, whereas the B. breve strain Yakult downregulates the expression of many genes (26) . Hoarau et al. suggested that B. breve can induce dendritic cell maturation through TLR2, with production of IL-10 regulating excessive Th1 responses as well as Th2 polarization (27) . Our findings support a possible mechanism for B. breve action in which it modulates inflammation by downregulating the expression of inflammatory molecules during the newborn period. It would also promote tolerance by upregulating the expression of CD3 but not costimulatory molecules during the weaning period. Further study is needed to determine the precise effects of B. breve in immune reactions during early infancy.
MetHODs
Study Design
All animal experiments were approved by the Juntendo University Animal Experimental Ethics Committee and complied with the National Institutes of Health guidelines for animal care.
B. breve Supplementation Study B. breve powder was commercially prepared from Morinaga Milk Industry (Zama, Japan), and this strain was deposited into the Belgian Co-Ordinated Collections of Micro-Organisms as strain LMG23729 (13) . B. breve was cultured for 16 h at 37 °C in M17 broth (Difco, Detroit, MI), collected by centrifugation, and washed twice with phosphate-buffered saline. F344/Du rat pups were used in this study (Japan SLC, Shizuoka, Japan). The pups were randomly divided into four groups soon after birth. One group received 5 × 10 8 colony-forming units/animal live B. breve plus starch dissolved in phosphate-buffered saline daily from days 1 to 14 after delivery (newborn group, n = 14) via an orogastric catheter. A second group received an equal amount of B. breve on days 21-34 (weaning group, n = 9). The remaining two groups were control groups that received starch alone during these periods (n = 14 and 9, respectively, for the newborn and weaning period control groups). During the newborn period, all rat pups received breast milk from their mothers from days 0 to 21. All rats were killed 14 days after B. breve administration, and their colons, small intestines, and spleens were removed and washed with phosphate-buffered saline. mRNA was extracted from a colon sample 1 cm proximal to the anus, from an ileal sample 1 cm proximal to the ileocecal valve, and from the spleen. The rest of each colon sample was fixed with formalin and embedded in paraffin for histological analysis.
DNA Extraction From Fecal Samples
DNA was extracted from fecal samples as previously described (14) . Briefly, fecal samples (20 mg) were washed three times in 1.0 ml phosphate-buffered saline and centrifuged at 13,000 rpm for 5 min. Fecal pellets were resuspended in 450 μl of extraction buffer (100 mM Tris/HCl, 40 mM EDTA, pH 9.0) and 50 μl of 10% sodium dodecyl sulfate. Glass beads (0.1 mm diameter, 300 mg) and 500 μl of buffer-saturated phenol were added to the suspension, and the mixture was vigorously vortexed for 30 s using a FastPrep FP 100A instrument (Funakoshi, Tokyo, Japan). After centrifugation at 13,000 rpm for 5 min, 400 μl of supernatant was extracted with phenol-chloroform, and 250 μl of supernatant was precipitated with isopropanol. Inhibitors were removed using a High Pure PCR Template Preparation Kit (Roche, Basel, Switzerland). Purified DNA was suspended in 200 μl of Tris-EDTA buffer (pH 8.0).
Real-Time PCR for Quantitative Determination of Bacteria
Real-time PCR analysis of microflora was performed using an ABI 7500 Fast Real-time PCR System (Applied Biosystems, Foster City, CA), SYBR Premix Ex Taq (Takara Bio, Shiga, Japan), and ROX reference dye II (Takara Bio) as an internal standard. Primer sets were previously reported: total bacteria and Bacteroides/Prevotella (15) , Bifidobacterium (16) , and Lactobacillus (17) . The amplification program consisted of 1 cycle at 95 °C for 20 s followed by 40 cycles at 95 °C for 3 s, 60 °C for 30 s, and 72 °C for 30 s. Fluorescent products were detected at the last . the staining with anti-CD86 antibody was light in both groups and showed no significant difference between the control (e,f) and B. breve groups (g,h). Original magnification ×400.
